Your Mounjaro Last Dose: What It Means and What Happens Next

You've just pressed the button on dose four, here's what's normal

Picture the moment: you've rotated through your injection sites over four weeks, and you're now pressing the button on what the pen tells you is the last dose. The plunger travels the same distance it always has. The 30-second hold is the same. What differs is what happens after, many people notice the pen locks or clicks distinctly at the end, and the dose counter shows it's finished. That's the pen working exactly as it should. Novo Nordisk designed the KwikPen to indicate clearly when the medicine is gone, reducing the chance of someone attempting a fifth injection from an empty barrel.

A question our prescribers hear most weeks is some version of: "I think I got less on the last one, did the pen run out early?" The honest answer is that the final dose is measured to the same standard as the first. If the plunger moved fully and you held for the full 30 seconds, you almost certainly received a complete dose. What sometimes feels different is the changed resistance in the pen body when it's nearly empty, it's a tactile thing, not a sign of a short dose. If you have real doubt, the right step is a message to your clinical team rather than an extra injection. You can read more about what to do if the pen appears to stop before the dose completes on the pen stuck on the last dose page.

One practical note: once the pen has locked, treat it as clinical waste. A sharps container is the safe, legally correct disposal route for used injection pens in the UK.

Can you actually use the last dose, or should you hold back?

There's a persistent idea that the last dose in any injectable medicine is somehow less reliable, drawn from old experiences with vials and syringes where air could contaminate a final draw. The Mounjaro KwikPen doesn't work that way. It's a pre-filled, pre-set device: each of the four doses is already measured inside the pen's cartridge, and the mechanism delivers them sequentially without you drawing anything up. The fourth is not the dregs.

So yes, you should use it. Skipping the last dose would mean missing a full week of treatment. Given that tirzepatide's effects build over a titration schedule that your prescriber has set, an unnecessary gap matters clinically. The detailed answer on whether to use the last dose covers the mechanics in full if you want to go deeper. The short version: take it, hold for the full time, and dispose of the pen safely afterwards.

One thing that does occasionally happen is the pen jamming before the final dose completes. That's a separate issue from simply reaching the end of the pen, if the pen appears to have jammed mid-injection, the guidance on a jammed pen walks through what to check. Don't attempt to force the mechanism; contact your prescriber or pharmacy if you're unsure how much was delivered.

The NHS tirzepatide medicines page has straightforward guidance on injection technique and what the pen should feel like at each stage, worth a read if this is your first course of treatment.

After the last dose: timing your next pen and clinical review

The last dose in your pen is also the prompt to think about what comes next in your treatment. Your next injection is due seven days later, as always, the four-dose pen covers four weeks, and the schedule doesn't change just because you're crossing from one pen to the next. Letting the gap extend beyond a week without clinical reason can affect how well the medicine maintains its effect. If your supply isn't lined up before the last pen runs out, sorting that promptly matters.

At nume (sorry, at Mounjaro treatment through a regulated UK provider) this is the natural point at which a clinical review happens before any repeat is dispensed. A prescriber looks at how the current dose has suited you, whether titration is appropriate, and whether continuing is the right step. That's not a formality; it's how safe prescribing works for a prescription-only medicine. If you're thinking about what Mounjaro costs across a full course, the Mounjaro cost context page gives an honest picture of UK private pricing.

The duration of each starting-dose pen and similar questions about how long specific strengths last in the body are answered in the related pages below, the active ingredient stays in your system for a week, which is why once-weekly dosing works. For those on higher doses, the 10mg tirzepatide duration page covers the pharmacology in plain terms.

If you've noticed other changes during your first course (missed or irregular periods, for instance) those questions are worth raising at your next clinical review. The Mounjaro and missed periods page covers what's known about this.

When you're ready to discuss your next steps with a prescriber, start your free consultation with the nume team, a real clinician reads your answers the same day.